Disclosure Of Non-Current Assets Held For Sale And Discontinued Operations [Text Block]

Transgene - Filing #2810948

Concept 2023-01-01 to
2023-12-31
2022-01-01 to
2022-12-31
Disclosure of non-current assets held for sale and discontinued operations [text block]
Disclosure of analysis of single amount of discontinued operations [text block]
Disclosure of analysis of single amount of discontinued operations [abstract]
Disclosure of analysis of single amount of discontinued operations [line items]
Profit (loss) before tax
22 328 EUR
32 804 EUR
Cash flows from continuing and discontinued operations [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operating activities
34 671 EUR
20 303 EUR
Cash flows from (used in) investing activities [abstract]
Cash flows from (used in) investing activities
34 572 EUR
20 272 EUR
Cash flows from (used in) financing activities [abstract]
Cash flows from (used in) financing activities
11 369 EUR
1 477 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.